Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up

Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up

Background: Patients on hemodialysis (HD) are at higher risk for COVID-19, overall are poor responders to vaccines, and were prioritized in the Portuguese vaccination campaign.Objective: This work aimed at evaluating in HD patients the immunogenicity of BTN162b2 after the two doses induction phase,...

Full description

Bibliographic Details
Main Authors: André Weigert, Marie-Louise Bergman, Lígia A. Gonçalves, Iolanda Godinho, Nádia Duarte, Rita Abrantes, Patrícia Borges, Ana Brennand, Vanessa Malheiro, Paula Matoso, Onome Akpogheneta, Lindsay Kosack, Pedro Cruz, Estela Nogueira, Magda Pereira, Ana Ferreira, Marco Marques, Telmo Nunes, João Faro-Viana, Jocelyne Demengeot, Carlos Penha-Gonçalves
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Medicine
Subjects:
BNT162b2
chronic hemodialysis
COVID-19
IgG
SARS-CoV-2
vaccine
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.796676/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.796676/full

Similar Items